Literature DB >> 11075869

Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States).

C I Li1, M A Rossing, L F Voigt, J R Daling.   

Abstract

BACKGROUND: Breast and thyroid cancer have been observed to occur more frequently than expected as multiple primary tumors in women. The study presented herein focuses on the effects of age at diagnosis and treatment for the first cancer on the development of the second cancer.
METHODS: This retrospective cohort study used a study population consisting of 38,632 women diagnosed with primary invasive breast cancer and 2189 women diagnosed with primary invasive thyroid cancer between 1974 and 1994. Cases were identified from records of the Cancer Surveillance System of western Washington and followed for subsequent cancer development through 1995.
RESULTS: Seventy-one women were diagnosed during their lives with both breast and thyroid cancers. Including cancers diagnosed during the same month as or after the initial cancer, the relative risk (RR) of breast cancer among women with thyroid cancer was 1.5 (95% confidence interval [CI] 1.1-2.0), and the RR of thyroid cancer among women with breast cancer was 1.5 (95% CI 1.1-2.2). Among women with thyroid cancer, risk of breast cancer was greatest when the latter cancer was diagnosed under 45 years of age (RR = 2.3, 95% CI 1.1-4.4). First course of treatment, including radiation or hormonal therapy to treat thyroid cancer, and radiation, chemotherapy, or hormonal therapy to treat breast cancer, did not alter a woman's risk of developing the second cancer.
CONCLUSIONS: The data suggest that the incidence of breast and thyroid cancer may be related, and that in particular women with thyroid cancer may be at a moderately increased risk of developing breast cancer before age 45.

Entities:  

Mesh:

Year:  2000        PMID: 11075869     DOI: 10.1023/a:1008942616092

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

Review 1.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

2.  A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.

Authors:  Carolina Pires; Inês Jorge Marques; Daniela Dias; Ana Saramago; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2021-03-08       Impact factor: 3.633

3.  Carcinoma showing thymus-like elements of the thyroid gland: report of three cases including one case with breast cancer history.

Authors:  Guanjun Zhang; Xi Liu; Wei Huang; Xiaofeng Li; Marianne Johnstone; Yuan Deng; Yongqiang Ke; Quentin M Nunes; Hongyan Wang; Yili Wang; Xuebin Zhang
Journal:  Pathol Oncol Res       Date:  2014-11-29       Impact factor: 3.201

4.  Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors.

Authors:  Christopher I Li; Nobuo Nishi; Jean A McDougall; Erin O Semmens; Hiromi Sugiyama; Midori Soda; Ritsu Sakata; Mikiko Hayashi; Fumiyoshi Kasagi; Akihiko Suyama; Kiyohiko Mabuchi; Scott Davis; Kazunori Kodama; Kenneth J Kopecky
Journal:  Cancer Res       Date:  2010-09-15       Impact factor: 12.701

5.  Sonographic detection of thyroid cancer in breast cancer patients.

Authors:  Jeong Seon Park; Ki Keun Oh; Eun-Kyung Kim; Eun-Ju Son; Hang-Seok Chang; Soon Won Hong; Hee Jung Moon; Kyu Sung Kwack
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

6.  A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population.

Authors:  S Vidal-Millan; I Zeichner-Gancz; D Flores-Estrada; B E Vela-Rodríguez; M I Vazquez-López; C D Robles-Vidal; M T Ramirez-Ugalde; M Chávez-MacGregor
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

7.  Long-term survival in young women: hazards and competing risks after thyroid cancer.

Authors:  Antoinette M Stroup; C Janna Harrell; Kimberly A Herget
Journal:  J Cancer Epidemiol       Date:  2012-10-02

8.  Second primary malignancies in thyroid cancer patients.

Authors:  C Rubino; F de Vathaire; M E Dottorini; P Hall; C Schvartz; J E Couette; M G Dondon; M T Abbas; C Langlois; M Schlumberger
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

9.  Iodine stimulates estrogen receptor singling and its systemic level is increased in surgical patients due to topical absorption.

Authors:  Shaohua He; Bingchan Wang; Xiyi Lu; Suyu Miao; Fengming Yang; Theodore Zava; Qiang Ding; Shijiang Zhang; Jiayin Liu; David Zava; Yuenian Eric Shi
Journal:  Oncotarget       Date:  2017-09-04

10.  Investigating the association of rs2910164 with cancer predisposition in an Irish cohort.

Authors:  T P McVeigh; R J Mulligan; U M McVeigh; P W Owens; N Miller; M Bell; F Sebag; C Guerin; D S Quill; J B Weidhaas; M J Kerin; A J Lowery
Journal:  Endocr Connect       Date:  2017-09-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.